Miliary Never-Smoking Adenocarcinoma of the Lung Strong Association with Epidermal Growth Factor Receptor Exon 19 Deletion

被引:47
作者
Laack, Eckart [1 ]
Simon, Ronald [2 ]
Regier, Marc [3 ]
Andritzky, Birte [4 ]
Tennstedt, Pierre [2 ]
Habermann, Christian [3 ]
zur Verth, Christoph
Thoem, Ina [4 ]
Grob, Tobias [2 ]
Sauter, Guido [2 ]
Bokemeyer, Carsten [4 ]
机构
[1] Ambulantes Krebszentrum Hamburg, D-22527 Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg, Dept Pathol, Hamburg, Germany
[3] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg, Dept Diagnost & Intervent Radiol, Ctr Diagnost, Hamburg, Germany
[4] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg, Dept Hematol & Oncol, Hamburg, Germany
关键词
Adenocarcinoma of the lung; EGFR exon 19 deletion; EGFR tyrosine kinase inhibitor; Miliary lung metastases; Never smoker; CARCINOMA;
D O I
10.1097/JTO.0b013e3181fb7cf1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Miliary pattern of pulmonary metastases is a rarity in patients with lung cancer. We report five cases of patients with a never-smoking adenocarcinoma of the lung with such a pattern of metastases. In the tumor cells of all five patients, epidermal growth factor receptor (EGFR) mutation gene sequencing identified a deletion in exon 19 of the EGFR gene, and all five patients had a dramatic response to EGFR tyrosine kinase inhibitors. No echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) translocation was detected. We believe that the miliary never-soking adenocarcinoma of the lung is a distinct clinically relevant subgroup of the never-smoking non-small cell lung cancer. Physician should recognize this subgroup of patients with lung cancer when facing a picture of miliary pulmonary metastases in chest x-ray or computed tomography scan in patients with a history of never smoking and consider upfront therapy with EGFR tyrosine kinase inhibitors.
引用
收藏
页码:199 / 202
页数:4
相关论文
共 4 条
[1]   Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib [J].
Lynch, TJ ;
Bell, DW ;
Sordella, R ;
Gurubhagavatula, S ;
Okimoto, RA ;
Brannigan, BW ;
Harris, PL ;
Haserlat, SM ;
Supko, JG ;
Haluska, FG ;
Louis, DN ;
Christiani, DC ;
Settleman, J ;
Haber, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2129-2139
[2]   Pictorial review of the many faces of bronchioloalveolar cell carcinoma [J].
Patsios, D. ;
Roberts, H. C. ;
Paul, N. S. ;
Chung, T. ;
Herman, S. J. ;
Pereira, A. .
BRITISH JOURNAL OF RADIOLOGY, 2007, 80 (960) :1015-1023
[3]  
Sebastian M, 2009, INTERNIST, V50, P91, DOI 10.1007/s00108-008-2239-0
[4]   ASSOCIATION OF MILIARY LUNG METASTASES AND BONE METASTASES IN BRONCHOGENIC-CARCINOMA [J].
UMEKI, S .
CHEST, 1993, 104 (03) :948-950